Drug intelligence / Profile preview

miR-654 mimic

Development stage
Preclinical
Modality
MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
In Vivo Studies: Local Injection, Systemic Injection (preclinical/research Context), In Vitro: Transfection
01

Overview

miR-654 mimic refers to a synthetic, exogenously delivered oligonucleotide that closely resembles the mature form of the naturally occurring microRNA miR-654 (either miR-654-3p or miR-654-5p) and is used to upregulate or “mimic” its activity in cells or organisms. It is typically used as an experimental therapeutic or research tool. miR-654 mimics exert their effect by increasing the intracellular levels of the respective miR-654 strand, thus promoting downregulation of target mRNAs through RNA-induced silencing complex (RISC) activity. Studies indicate that overexpression of miR-654-3p or miR-654-5p via mimics can suppress tumor growth, proliferation, migration, and invasion in a variety of cancer models, and influence chemosensitivity and epithelial-to-mesenchymal transition. For example, in non-small cell lung cancer, the miR-654-3p mimic decreased PLK4 mRNA and protein levels, leading to reduced tumor growth[1]. In colorectal cancer, miR-654-3p mimic downregulated SRC and inhibited invasion and metastasis[2]. In other models, distinct targets like CREB1, PSEN1, or QPRT have been validated, mediating tumor-suppressor or context-dependent oncogenic effects[3][5]. miR-654-5p mimics have also shown utility as experimental tools for modulating cell migration and proliferation in vascular disease or cancer[7].

Other names
miR-654-3p mimicmiR654-3p mimicmiR 654-3p mimicmiR-654-5p mimicmiR654-5p mimicmiR 654-5p mimicmicroRNA-654 mimicmicroRNA654 mimicmicroRNA 654 mimic
02

Targets

Cyclic AMP-responsive element-binding protein 1 mRNA (CREB1 mRNA)PSEN1 (Presenilin 1)QAPRT (Quinolinic acid phosphoribosyltransferase)

Beyond the preview

Go deeper on miR-654 mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-654 mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call